MISSION
Our mission is to develop novel therapeutics and biomarkers for liver cancer. We conduct basic and translational research using genomic data from human HCC, mouse models of liver cancer, and patient derived xenografts. We are deciphering the molecular biology of hepatocellular carcinoma (HCC) using innovative methods, cutting-edge techniques, and interdisciplinary collaborative approach. Furthermore, recruiting and training the future generation of researchers is a key component of our mission
VISION
Discover a cure for liver cancer through innovative experimentation.
CORE VALUES
.We believe People come first.
We value Innovation and Creativity.
We strive for Excellence with Integrity.
NEWS AND EVENTS
AASLD Presidential Plenary Oral Presentation
Our Research Assistant Akanaksha presenting a study on spatial transcriptomics in liver cancer at the international conference DDW 2022 at San Diego, CA.
AASLD 2022 Basic Science Presidential Plenary Oral Presentation
Akanksha presenting our data on spatial biology of HCC at the Liver Meeting 2022 at Washington DC in November 2022. She also received a travel award to present her research.